Biotechnology

Hutch hosts lecture series for the public next month

Hutch hosts lecture series for the public next month

Next month, Fred Hutchinson Cancer Research Center offers its annual “Science for Life” series in which the center’s top researchers will explain the latest science in a fun and informal atmosphere.

Share
January 24, 2012 | 0 Comments More
Photo Credit: Dan Higgins/CDC

Holiday health reading: Journals and the killer flu, why women have late abortions, and unhappy hospital docs

Why do mothers seek abortions late in their pregnancies? How much detail should journals provide about killer flu research? Obama originally opposed the individual mandate and Romney supported it – now it’s the other way round. What’s up with that?

Share
December 28, 2011 | 0 Comments More
Generic Lipitor now at stores near you

Generic Lipitor now at stores near you

How much might you save on Lipitor now? If you have insurance, you should be able to get atorvastatin for the price of a generic copayment. Around $10 is typical.

Share
December 20, 2011 | 0 Comments More
RNAi explained: Animation by Ballard’s Arkitek Studios

RNAi explained: Animation by Ballard’s Arkitek Studios

A video explaining RNA interference — or RNAi — from the journal Nature Reviews Genetics. The animation by Ballard-based Arkitek Studios.

Share
December 20, 2011 | 0 Comments More
Finding cures for rare diseases: Film and discussion, Dec. 13th

Finding cures for rare diseases: Film and discussion, Dec. 13th

NWABR’s Community Conversation Series this month will include a showing of excerpts from the soon to be released film RARE, a documentary about the struggle to find new treatments for Hermansky-Pudlak Syndrome (HPS), a rare genetic disorder.

Share
December 3, 2011 | 0 Comments More
Animal research can be humane and ethical — animal psychologist argues

Animal research can be humane and ethical — animal psychologist argues

The use of animals in medical research is justified provided that the research is worthwhile and that animals are treated humanely, noted animal psychologist Temple Grandin argues.

Share
December 2, 2011 | 8 Comments More
State’s life sciences sector grows despite recession

State’s life sciences sector grows despite recession

Despite a recession, the number of jobs in Washington state’s life sciences sector rose 9 percent from 2007 through the first quarter of this year, according to a report released at the Washington Biotechnology & Biomedical Associations 2011 Governor’s Life Sciences Annual.

Share
November 28, 2011 | 0 Comments More
FDA pulls approval of Avastin for breast cancer

FDA pulls approval of Avastin for breast cancer

After more than a year of deliberations, the FDA has revoked approval of the biotech blockbuster Avastin, a medicine that chokes off the blood supply to various cancer cells, as a treatment for metastatic breast cancer.

Share
November 18, 2011 | 1 Comment More
Drug shortages affect more than half a million cancer patients

Drug shortages affect more than half a million cancer patients

So far this year, shortages of 200 drugs — treatments for conditions ranging from cancer to high blood pressure — have been reported. How many patients have been affected? Try 550,000 cancer patients alone for the year that ended June 30.

Share
November 16, 2011 | 0 Comments More
Physicians strongly favor larger role for palliative care — poll

Physicians strongly favor larger role for palliative care — poll

96 percent responding that they believe enhancing the quality of life for seriously ill patients is more important than extending life as long as possible.

Share
November 16, 2011 | 0 Comments More
Cystic fibrosis drug improves lung function and symptoms, Seattle-led study finds

Cystic fibrosis drug improves lung function and symptoms, Seattle-led study finds

A new drug, called ivacaftor or VX-770, significantly improves lung function and other symptoms in cystic fibrosis patients with a specific mutation — Seattle Childrens/UW study finds

Share
November 14, 2011 | 0 Comments More
CDC microbiologist - Photo: James Gathany

Public health, medical research face deep cuts if super committee deadlocks

Federal funding for medical research, disease prevention and a host of public health initiatives could be sharply reduced if the congressional super committee fails to agree on a deficit-reduction package, triggering automatic cuts.

Share
October 18, 2011 | 0 Comments More